http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100448298-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-87 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate | 1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100448298-B1 |
titleOfInvention | Glucocotricoid enhancement of gene expression |
abstract | The present invention relates to a method for the treatment and / or prophylaxis of cancer, comprising administering to the animal a pharmacologically effective dose of a glucocorticoid in an amount sufficient to increase cellular expression of a particular gene, Lt; RTI ID = 0.0 > expression. ≪ / RTI > The invention also relates to a method for the treatment of a pathological physiological condition in a mammal, comprising administering to the animal an effective amount of a glucocorticoid in an amount sufficient to increase cellular expression of a particular gene, And various methods of treating the pathophysiological condition in a human by increasing the cell expression of the gene after it has been delivered into a tissue. |
priorityDate | 1995-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 344.